BOONE—Volunteers are being sought for a research study of the effect of the supplement Wellmune WGP on immune function and anti-viral activity.
Women between the ages of 50 and 70 are needed for this study, which has been approved by the university’s Institutional Review Board and is being directed by Dr. David C. Nieman from the Human Performance Lab in the College of Health Sciences at Appalachian State University.
The research study will measure the effect of ingesting Wellmune WGP, which contains a special molecule from baker’s yeast that may enhance the body’s immune system. Volunteers selected for the study will be divided into two groups. One group will take 250 milligrams a day of Wellmune WGP, derived from baker’s yeast, or placebo containing rice flour. After taking no supplement for 14 days, the groups will switch to the opposite treatment, the Wellmune WGP group taking the placebo and the placebo group taking the Wellmune WGP.
Healthy, nonsmoking, postmenopausal females between the ages of 50 and 70 years, and who weigh 25 pounds or more than is recommended for their height, may qualify for this study.
Volunteers must not be on cholesterol-lowering or blood pressure-lowering medications in order to participate. Additional details, including other health parameters that will be required, are available from Melanie Austin in the Human Performance Lab.
Participants will receive $200 for adhering to all aspects of the study design and personal results from the blood immune tests. To sign up for the study, email email@example.com.